Gwella, the designers of mushrooms for modern life, announces the launch of Mojo, a first of its kind gummy that simulates the reported pharmacological effects of microdosing psilocybin, engineered to optimize performance by harnessing the power of fully legal mushrooms and botanicals.

The result of 12 months of R&D, Mojo contains a complex blend of 14 active ingredients including their proprietary full-spectrum Cordyceps Sinensis (CS-4) mushroom concentrate.  Expertly grown to minimize any impurities commonly found in other grow methods, this product is the first of its kind in the United States when it comes to strength and purity.  Due to advances in modern technology, it is now possible to create a strain with a higher concentration of active compounds than those products commonly found on the market.  

Read full article here